美国 · SEC FORM 4
Vor Biopharma Inc.
VOR · Nasdaq · CIK 0001817229 · Healthcare · Biotechnology
内部人信号
当前没有活跃买入信号
0 qualifying P purchase groups
当前 180 天评分窗口
5 同一窗口内观察到的 Form 4 交易行
2 sales · 3 期权、代扣税、授予、赠与或其他交易行
最近一次合资格买入2024-12-30 · Hoffman Reid; Reprogrammed Interchange LLC · value unavailable
为什么没有活跃信号？
买入活动无
近期买入无
近期卖出较低
买入信号状态未激活
评分构成
活跃窗口内没有合资格买入，因此不计算分数。缺失的输入不会被当作零分或看空信号。
Cluster未计算
买入规模未计算
角色未计算
近期性未计算
确信度未计算
为什么没有分数？
- 没有合资格公开市场买入可提供聚集度、规模、角色、近期性或确信度输入。
- 卖出及其他 Form 4 活动继续作为背景显示，不会形成负分。
卖出和其他 Form 4 活动会单独显示，不会形成负面买入信号。没有买入不会被评分为看空。
买方广度、集中度与聚集买入
合资格买入进入 180 天研究窗口后，这些模块才会启用。
内部人活动时间轴
申报人轨道展示最近 180 天。符号形状区分交易类型；卖出仅作为背景。
AprMayJunJulAugSepOct
Kolchinsky Peter; RA CAPITAL MANAGEMENT, L.P.; RA Capital Healthcare Fund LP; Shah Rajeev M.TenPercentOwner
▼▼○○○
● 买入▼ 卖出○ 其他
—
信号历史
暂无已记录的活跃信号快照
Scores are archived only when the company qualifies for a published US buy-signal snapshot. 最近一次合资格买入: 2024-12-30 · Hoffman Reid; Reprogrammed Interchange LLC.
近期 Form 4 活动
0买入
30卖出
5其他 Form 4 交易行
14SEC 申报 · 365天
买入0 qualifying P line(s) · 180 days
卖出2 sale line(s) · 仅供背景
其他3 exercise / withholding / award / gift / other lines
10b5-1／计划交易Not assessed
P is an open-market or private purchase. S is a sale. M, F, A and G usually describe exercises, tax withholding, awards and gifts. These categories remain visually separate.
市场背景
该股票尚未获取市场背景。每日任务会轮转处理美国股票池。
空头余额
空头余额是券商向 FINRA 申报的外部背景数据，不影响内部人信号。
- 空头股数
- 7,814,764
- 上期报告
- 7,904,520
- 日均成交量
- 1,801,970
- 回补天数
- 4.3
FINRA 结算日：2026-09-30 · 获取日期 2026-10-12 · FINRA 股票空头余额 ↗. 这是股数，每月两个结算日之后约一周公布；不是占已发行股份的比例。
历史股票买入
Qualifying code P transactions in the local Form 4 history, including purchases outside the current signal window.
| Transaction date | Reporting owner | 类型 | 证券 | 股数 | 平均价格 | 估算金额 | 来源 |
|---|---|---|---|---|---|---|---|
| 2024-12-30 | Hoffman Reid; Reprogrammed Interchange LLC | 买入 (P) | Common Stock | 38,974,101 | USD — | USD — | SEC 申报 ↗ |
| 2021-02-09 | PARMAR KUSH | 买入 (P) | Common Stock | 555,555 | USD 18.00 | USD 9,999,990 | SEC 申报 ↗ |
| 2021-02-09 | Kolchinsky Peter; RA CAPITAL MANAGEMENT, L.P.; RA Capital Healthcare Fund LP; Shah Rajeev M. | 买入 (P) | Common Stock | 2,979,566 | USD 18.00 | USD 53,632,188 | SEC 申报 ↗ |
| 2021-02-09 | 5AM Opportunities I (GP), LLC; 5AM Opportunities I, L.P.; 5AM Partners VI, LLC; 5AM Ventures VI, L.P.; Schwab Andrew J. | 买入 (P) | Common Stock | 555,555 | USD 18.00 | USD 9,999,990 | SEC 申报 ↗ |
Form 4 申报证据
35 transaction lines in the latest 365-day window; 204 in local history.
| 日期 | 申报人 | 类型 | 证券 | 股数 | 平均价格 | 估算金额 | 来源 |
|---|---|---|---|---|---|---|---|
| 2026-10-02 | Kolchinsky Peter; RA CAPITAL MANAGEMENT, L.P.; RA Capital Healthcare Fund LP; Shah Rajeev M. | 期权行权／转换 (M) | Common Stock | 500 | USD 12.80 | USD 6,400 | SEC 申报 ↗ |
| 2026-08-24 | Kolchinsky Peter; RA CAPITAL MANAGEMENT, L.P.; RA Capital Healthcare Fund LP; Shah Rajeev M. | 期权行权／转换 (M) | Common Stock | 1,500 | USD 3.74 | USD 5,610 | SEC 申报 ↗ |
| 2026-07-16 | Kolchinsky Peter; RA CAPITAL MANAGEMENT, L.P.; RA Capital Healthcare Fund LP; Shah Rajeev M. | X (X) | Common Stock | 2,100,000 | USD 0.00 | USD 0 | SEC 申报 ↗ |
展开近期 Form 4 证据 (27 grouped rows)
| 日期 | 申报人 | 类型 | 证券 | 股数 | 平均价格 | 估算金额 | 来源 |
|---|---|---|---|---|---|---|---|
| 2026-10-02 | Kolchinsky Peter; RA CAPITAL MANAGEMENT, L.P.; RA Capital Healthcare Fund LP; Shah Rajeev M. | 期权行权／转换 (M) | Common Stock | 500 | USD 12.80 | USD 6,400 | SEC 申报 ↗ |
| 2026-08-24 | Kolchinsky Peter; RA CAPITAL MANAGEMENT, L.P.; RA Capital Healthcare Fund LP; Shah Rajeev M. | 期权行权／转换 (M) | Common Stock | 1,500 | USD 3.74 | USD 5,610 | SEC 申报 ↗ |
| 2026-07-16 | Kolchinsky Peter; RA CAPITAL MANAGEMENT, L.P.; RA Capital Healthcare Fund LP; Shah Rajeev M. | X (X) | Common Stock | 2,100,000 | USD 0.00 | USD 0 | SEC 申报 ↗ |
| 2026-07-16 | Kolchinsky Peter; RA CAPITAL MANAGEMENT, L.P.; RA Capital Healthcare Fund LP; Shah Rajeev M. | 卖出 (S) | Common Stock | 213 | USD 19.75 | USD 4,207 | SEC 申报 ↗ |
| 2026-04-22 | Kolchinsky Peter; RA CAPITAL MANAGEMENT, L.P.; RA Capital Healthcare Fund LP; Shah Rajeev M. | 卖出 (S) | Common Stock | 165,150 | USD 15.77 | USD 2,604,416 | SEC 申报 ↗ |
| 2026-04-20 | Kolchinsky Peter; RA CAPITAL MANAGEMENT, L.P.; RA Capital Healthcare Fund LP; Shah Rajeev M. | 卖出 (S) | Common Stock | 171,963 | USD 15.77 | USD 2,711,857 | SEC 申报 ↗ |
| 2026-04-17 | Kolchinsky Peter; RA CAPITAL MANAGEMENT, L.P.; RA Capital Healthcare Fund LP; Shah Rajeev M. | 卖出 (S) | Common Stock | 458,411 | USD 16.28 | USD 7,462,931 | SEC 申报 ↗ |
| 2026-04-15 | Kolchinsky Peter; RA CAPITAL MANAGEMENT, L.P.; RA Capital Healthcare Fund LP; Shah Rajeev M. | 卖出 (S) | Common Stock | 53,644 | USD 16.01 | USD 858,840 | SEC 申报 ↗ |
| 2026-04-14 | Kolchinsky Peter; RA CAPITAL MANAGEMENT, L.P.; RA Capital Healthcare Fund LP; Shah Rajeev M. | 卖出 (S) | Common Stock | 153,735 | USD 15.97 | USD 2,455,148 | SEC 申报 ↗ |
| 2026-04-13 | Kolchinsky Peter; RA CAPITAL MANAGEMENT, L.P.; RA Capital Healthcare Fund LP; Shah Rajeev M. | 卖出 (S) | Common Stock | 530,610 | USD 16.15 | USD 8,569,352 | SEC 申报 ↗ |
| 2026-04-10 | Kolchinsky Peter; RA CAPITAL MANAGEMENT, L.P.; RA Capital Healthcare Fund LP; Shah Rajeev M. | 卖出 (S) | Common Stock | 828 | USD 15.75 | USD 13,041 | SEC 申报 ↗ |
| 2026-04-09 | Kolchinsky Peter; RA CAPITAL MANAGEMENT, L.P.; RA Capital Healthcare Fund LP; Shah Rajeev M. | 卖出 (S) | Common Stock | 135,201 | USD 16.59 | USD 2,242,985 | SEC 申报 ↗ |
| 2026-04-08 | Kolchinsky Peter; RA CAPITAL MANAGEMENT, L.P.; RA Capital Healthcare Fund LP; Shah Rajeev M. | 卖出 (S) | Common Stock | 484,104 | USD 16.48 | USD 7,977,786 | SEC 申报 ↗ |
| 2026-04-06 | Kolchinsky Peter; RA CAPITAL MANAGEMENT, L.P.; RA Capital Healthcare Fund LP; Shah Rajeev M. | 卖出 (S) | Common Stock | 589,257 | USD 16.59 | USD 9,777,898 | SEC 申报 ↗ |
| 2026-04-02 | Kolchinsky Peter; RA CAPITAL MANAGEMENT, L.P.; RA Capital Healthcare Fund LP; Shah Rajeev M. | 卖出 (S) | Common Stock | 260,000 | USD 18.23 | USD 4,741,066 | SEC 申报 ↗ |
| 2025-12-18 | Kolchinsky Peter; RA CAPITAL MANAGEMENT, L.P.; RA Capital Healthcare Fund LP; Shah Rajeev M. | 奖励／授予 (A) | Common Stock | 4,625,346 | USD 10.81 | USD 49,999,990 | SEC 申报 ↗ |
| 2025-12-05 | Mahatme Sandesh | D (D) | Common Stock | 694,137 | USD 0.00 | USD 0 | SEC 申报 ↗ |
| 2025-10-30 | Kolchinsky Peter; RA CAPITAL MANAGEMENT, L.P.; RA Capital Healthcare Fund LP; Shah Rajeev M. | 卖出 (S) | Common Stock | 24,579 | USD 25.12 | USD 617,424 | SEC 申报 ↗ |
| 2025-10-29 | Kolchinsky Peter; RA CAPITAL MANAGEMENT, L.P.; RA Capital Healthcare Fund LP; Shah Rajeev M. | 卖出 (S) | Common Stock | 251,518 | USD 25.22 | USD 6,343,284 | SEC 申报 ↗ |
| 2025-10-28 | Kolchinsky Peter; RA CAPITAL MANAGEMENT, L.P.; RA Capital Healthcare Fund LP; Shah Rajeev M. | 卖出 (S) | Common Stock | 124,311 | USD 27.42 | USD 3,408,230 | SEC 申报 ↗ |
| 2025-10-27 | Kolchinsky Peter; RA CAPITAL MANAGEMENT, L.P.; RA Capital Healthcare Fund LP; Shah Rajeev M. | 卖出 (S) | Common Stock | 90,941 | USD 28.12 | USD 2,557,261 | SEC 申报 ↗ |
| 2025-10-24 | Kolchinsky Peter; RA CAPITAL MANAGEMENT, L.P.; RA Capital Healthcare Fund LP; Shah Rajeev M. | 卖出 (S) | Common Stock | 53,345 | USD 28.01 | USD 1,494,193 | SEC 申报 ↗ |
| 2025-10-23 | Kolchinsky Peter; RA CAPITAL MANAGEMENT, L.P.; RA Capital Healthcare Fund LP; Shah Rajeev M. | 卖出 (S) | Common Stock | 76,880 | USD 28.01 | USD 2,153,409 | SEC 申报 ↗ |
| 2025-10-21 | Kolchinsky Peter; RA CAPITAL MANAGEMENT, L.P.; RA Capital Healthcare Fund LP; RA Capital Nexus Fund, L.P.; Shah Rajeev M. | 卖出 (S) | Common Stock | 25,027 | USD 28.11 | USD 703,509 | SEC 申报 ↗ |
| 2025-10-21 | Hoffman Reid; Reprogrammed Interchange LLC | 卖出 (S) | Common Stock | 200 | USD 30.08 | USD 6,016 | SEC 申报 ↗ |
| 2025-10-20 | Kolchinsky Peter; RA CAPITAL MANAGEMENT, L.P.; RA Capital Healthcare Fund LP; RA Capital Nexus Fund, L.P.; Shah Rajeev M. | 卖出 (S) | Common Stock | 92,023 | USD 29.67 | USD 2,730,483 | SEC 申报 ↗ |
| 2025-10-20 | Hoffman Reid; Reprogrammed Interchange LLC | 卖出 (S) | Common Stock | 11,616 | USD 30.05 | USD 349,061 | SEC 申报 ↗ |
Multiple price lines in one filing are grouped and share-weighted. Price and value are blank when a grouped filing line lacks price evidence.
快照与身份
| 快照日期 | 2026-10-19 |
|---|---|
| 排名版本 | US-v1.2 |
| 数据质量 | PASS ELIGIBLE · — |
| 股票代码 | VOR |
| CIK | 0001817229 |
| 行业 | Healthcare |
| 细分行业 | Biotechnology Yahoo Finance |
| SEC SIC | 2836 Biological Products, (No Diagnostic Substances) |
| 交易所 | Nasdaq |
数据覆盖
| 本地 Form 4 历史 | 204 transaction lines from 2021-02-09 to 2026-10-02 7 P purchase lines · 94 S sale lines · 103 other lines |
|---|---|
| SEC 公司申报 | 打开 SEC 申报 ↗ |
Local ledger as of 2026-10-19. Mapping status is an audit field and does not erase SEC filing evidence.